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Abstract 
The present study investigated the perceptual, attentional and memory processes underlying 
face recognition deficits observed in older adults with impaired glucoregulation. Participants 
were categorised as good glucoregulators or poor glucoregulators on the basis of an oral 
glucose tolerance test (OGTT). Using event-related potential (ERP) methodology, 23 
participants (18 females, range = 62 to 88 years old, mean age = 73.87 years old, SD = 8.41) 
performed a 2-stimulus oddball task. Participants were asked to rate and memorise 10 ‘target’ 
faces, which were then presented amongst 120 unfamiliar foils. Behavioural results indicated 
that good glucoregulators were significantly more accurate at recognising target faces. ERP 
markers of early visual perception (the P1 and N170 components) and memory formation (the 
P3 component) were unaffected by glucoregulatory efficiency. The P2 component, an index of 
attentional processing, was larger and delayed in the poor glucoregulators. To the best of our 
knowledge, the present study is the first to suggest that face recognition deficits in poor 
glucoregulators may be due to impairments in attentional processing.  
 
Key words: event-related potentials, glucoregulation, oddball paradigm, face recognition, 
ageing 
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Introduction 
Impairments in glucoregulation are associated with cognitive deficits in older adults 
(Meikle, Riby & Stollery, 2004; Messier, 2005; Riby et al., 2009; Riby & Riby, 2006). These 
deficits are observable in individuals with chronically impaired glucoregulation (e.g. Jones, 
Riby & Smith, 2016) and impaired glucose tolerance (e.g. Vanhanen et al., 1998). Cognitive 
impairment has also been demonstrated in healthy older adults with relatively poorer glucose 
regulation (i.e. individuals who demonstrate no overt signs of diabetes but have an increased 
blood glucose level in response to an oral glucose tolerance test; e.g. Messier, Tsiakas, Gagnon, 
Desrochers & Awad, 2003; Messier, Tsiakas, Gagnon, & Desrochers, 2010). Deficits are 
frequently observed in a number of cognitive domains including executive functioning, 
information processing and verbal episodic memory (Manschot et al, 2007; Yeung, Fischer & 
Dixon, 2009; Smith et al., 2014; Jones, Riby, Mitchell & Smith, 2014). Hyperglycaemia has 
been purported as a mechanism underpinning the link between impaired glucoregulation and 
cognitive deficits (Strachan, Reynolds, Marioni & Price, 2011). The development of type 2 
diabetes has been shown to increase in healthy adults with increasingly poor glucoregulatory 
efficiency, even when this occurs within normal glucose tolerance limits (Levitan, Song, For 
& Liu, 2004). This suggests that progression of glucoregulatory problems occurs on a 
continuum and as such, investigating changes within a healthy population may shed light on 
the possible mechanisms underlying cognitive impairment in individuals with clinical 
impairments in glucoregulatory efficiency. 
Memory problems induced by impaired glucoregulatory efficiency are more typically 
seen in the verbal domain (Lamport, Lawton, Mansfield & Dye, 2009), with very little research 
considering nonverbal memory (Messier, 2005). Further, there has been limited consideration 
of links to cognitive visual perceptual mechanisms beyond the physically detrimental impact 
of diabetic retinopathy (Ding et al., 2010). However, there is evidence in the extant literature 
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which suggests that poor glucoregulation impacts on face recognition ability (Zaslavsky, Gross, 
Chaves & Machado, 1995; Fontbonne, Berr, Ducimetière, & Alpérovitch, 2001; Jones et al., 
2016). Indeed, Fontbonne and colleagues (2001) investigated cognitive function in older adults 
i) with type 2 diabetes (DM2), ii) individuals with impaired fasting glucose (IFG) levels, and 
iii) healthy controls, over a four-year period. They found that DM2 participants performed 
similarly to IFG and control participants at baseline but their performance deteriorated to a 
significantly greater extent on a number of measures, including face recognition, after the four 
year follow up. Reduced connectivity between the hippocampus and surrounding regions has 
been reported in those with DM2, and previous research suggests that a disruption in 
connectivity between the fusiform face area and the hippocampus could explain these face 
recognition deficits (Zhou et al., 2010). Further, it has been suggested that administration of 
glucose enhances face recognition performance in young adults and in Alzheimer’s patients 
(Manning, Ragozzino & Gold, 1993; Metzger & Flint Jr., 2003). This suggests that neural areas 
important to face recognition may be sensitive to impairments in glucose tolerance.  
The event-related potential (ERP) technique provides a methodology for assessing 
cognitive performance in situations where overt behavioural responses cannot be reliably 
obtained, and is very useful for investigating the train of perceptual and neurocognitive 
processes engaged during an activity (see influential volume by Luck, 2014). Although ERPs 
have not been employed in the ageing literature to investigate glucoregulatory mediated face 
processing ability, ERPs have been used previously to investigate both glucoregulatory 
influences on cognition and neurocognitive mechanisms underpinning face processing (e.g. 
Hissa, D’Almeida, Cremasco, & de Bruin, 2002; Wiese, Komes & Schweinberger, 2012). The 
ageing literature therefore provides a useful foundation on which to base our investigation, 
particularly given the established relationship between cognitive performance, glucoregulation 
and ageing (Lamport et al., 2009). Here we focus on the P1, N170, P2 and P3 components, 
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which have been used consistently as biological markers of early perceptual, attention and 
memory processes elicited during face recognition in an elderly population (Cooray et al., 
2011; Daniel & Bentin, 2012; Gao et al., 2009).  
 The P1 is the first positive ERP component associated with early visual perceptual 
processing that peaks approximately 100 ms post-stimulus onset. This component is sensitive 
to a number of early visual perception inputs including stimuli luminance and contrast and is 
elicited at scalp sites around the occipital region (Gao et al, 2009). While this component is not 
specifically associated with face processing (Rossion & Jacques, 2008), some studies have 
suggested that faces elicit a larger P1 component than non-face stimuli (e.g. Rossion & Caharel, 
2011). Older adults are known to exhibit relatively larger P1 amplitudes and delayed P1 
latencies relative to younger adults suggesting that this component becomes larger in amplitude 
and delayed in latency with cognitive deterioration in ageing (Gao et al., 2009). The most robust 
and frequently reported ERP component in face processing and recognition research is the 
N170 (Rossion & Jacques, 2008). This is a negative, early perceptual ERP component, peaking 
around 170 ms after stimulus onset, observed at occipito-temporal scalp sites, with higher 
amplitudes predominantly found for faces than other types of stimuli (Itier & Taylor, 2004). 
Evidence suggests it is face-sensitive and is related to the detection of structural features and 
configurations of the stimuli engaged prior to identification (Wiese, Schweinberger & Hansen, 
2008; Rossion & Jacques, 2008 for a review). The P2 component is a positive going deflection 
that usually follows the N170 component in face recognition tasks (Wolff, Wiese & 
Schweinberger, 2012), peaking approximately 200 ms post-stimulus onset over occipito-
parietal and temporal sites. This component is considered to reflect processes of perceptual and 
configural processing to enable subsequent face recognition (Latinus & Taylor, 2006; Zheng, 
Mondloch & Segolowitz, 2012). Smaller P2 amplitudes are associated with relatively better 
face recognition (Zheng et al., 2012), suggesting that amplitudes may be larger in individuals 
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with poor face recognition ability. A similar component has been observed in oddball tasks but 
over frontal and central electrode sites (Riby et al, 2008). This component is associated with 
higher level perceptual and attentional processing, particularly of visual stimuli, with increased 
amplitudes in response to repeated stimuli compared to novel stimuli (Curran & Dien, 2003; 
Luck & Hillyard, 1994; Evans & Federmeier, 2007; Riby et al., 2008). Impairments in 
attentional processing have been reported in relatively healthy older adults with an increased 
risk for type 2 diabetes (Vanhanen et al., 1997). Speculatively, impairments in attentional 
processing could be a mechanism underpinning the face recognition deficits associated with 
impaired glucoregulation. A further component that has been investigated in relation to both 
face recognition, and glucoregulation is the P3. This component is a positive deflection, 
observed at central frontal and parietal scalp sites, peaking approximately 300-350 ms post-
stimulus onset and often comprising two subcomponents depending on the paradigm: P3a 
(associated with executive function and automatic orientation of attention to task irrelevant 
stimuli) and the P3b (associated with memory updating and formation of memory 
representations; Polich, 2007). As the present study is focussed on the recognition (and 
therefore, memory) of faces, we are specifically interested only in the P3b component, which 
will be referred to herein as the P3. The P3 component is evoked by the oddball task, which 
measures sustained attention and identification of infrequently presented stimuli, and is 
maximal over frontal and central electrode sites (Polich, 2007). The investigation of this 
component in glucoregulation research has revealed that P3 latencies are significantly delayed 
and longer during an auditory oddball tasks in DM2 participants relative to healthy controls 
(Cooray et al., 2011; Hissa et al., 2002). The longer latencies observed may reflect delayed 
memory processing and consequently deficits in memory updating and formation in DM2 
(Polich, 2007).  
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 The preliminary findings demonstrate a clear association between impaired 
glucoregulatory efficiency and face recognition deficits (Zaslavsky et al., 1995; Fontbonne et 
al., 2001; Jones et al., 2016) and in conjunction with findings that face recognition declines as 
part of the normal ageing process (e.g. Boutet & Faubert, 2006; Lott, Haegerstrom-Portnoy, 
Schneck, & Brabyn, 2005) suggest that it is timely to investigate further i) whether impaired 
glucoregulatory efficiency in older adults is associated with face recognition deficits, and ii) 
the neurocognitive mechanisms associated with such deficits. That is, does impaired 
glucoregulation impact specifically upon such processes as i) general visual perception, ii) 
visual perception specific to faces, iii) attentional processing, iv) memory updating and 
formation, or v) a combination of these factors, with these deficits emerging as overt face 
recognition deficits in behavioural paradigms? The aim of the present study was to 
systematically investigate this question, by employing the temporal precision of ERP 
methodology. There were a number of specific predictions. First, if face recognition deficits 
observed in those with poor glucoregulation are due to inefficiency in early perceptual 
processing, the overall P1 and N170 amplitudes would be larger and their latencies longer in 
those with poor glucoregulation relative to those with good glucoregulation. Speculatively, 
ERP components affected by ageing may be more amenable and hence sensitive to impairments 
in glucoregulation, given that a relationship between glucoregulation, cognition and ageing has 
been suggested (Lamport et al., 2009). Secondly, if attention is critical to the observed deficits, 
it was predicted that the P2 amplitudes and latencies of poor glucoregulators would be 
significantly larger and delayed compared to good glucoregulators. Finally, if memory deficits 
underpin impaired face recognition performance in poorer glucoregulators, then predicated by 
Cooray and colleagues (2011), it was hypothesised that the latency of the P3 to infrequent target 
faces would be delayed in participants with poor glucoregulation compared to those with good 
glucoregulation. 
  
8 
 
Method 
Participants 
 
Twenty-three participants aged 60 years and over took part (18 females, range = 62 to 88 years 
old, mean age = 73.87 years old, SD = 8.41). The following exclusion criteria applied to all 
participants; participants were excluded if they: were under 60 years of age; were left-handed; 
were not proficient in English; were suffering from any serious medical (i.e. coronary disease, 
diabetes, asthma) or psychiatric condition (i.e. depression, anxiety related disorders) at the time 
of testing; had a diagnosis of dementia or memory disorder (e.g. mild cognitive impairment); 
were suffering from any acute viral infection (i.e. cold / flu) at the time of testing; had any 
learning difficulties or dyslexia; had a history of brain injury; had a diagnosis of diabetes (Type 
1 or Type 2), or other metabolic conditions which impact upon glucose regulation; had a visual 
impairment that could not be corrected with glasses or contact lenses; had any known active 
infections; were HIV antibody positive or thought they may be HIV positive; had at the time 
of testing, have ever had, or thought they may be at risk of hepatitis; had jaundice in the year 
prior to testing; had breast cancer and/or a mastectomy; had haemophilia or any similar blood 
clotting disorder. Participants were also excluded if their fasting blood glucose level exceeded 
6.1 mmol/l. 
Participants were recruited from an older adult participant database held at Northumbria 
University, as well as through local older adult groups and newsletters. Participants were given 
£15 as compensation for their time and out-of-pocket expenses. Written informed consent was 
obtained from all participants prior to testing. Ethical approval was obtained from the School 
of Life Sciences ethics committee at Northumbria University. 
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Participants were split into two groups based on their area-under-curve (AUC) 
measurements on the oral glucose tolerance test (OGTT), categorised by median split into 11 
‘poor’ and 12 ‘good’ glucoregulators. Table 1 shows the descriptive statistics for each group. 
The mean blood glucose levels at each time point across the two-hour period are shown for 
each glucoregulatory group in Figure 1. No significant differences were observed between the 
two groups in terms of age, BMI, National Adult Reading Test (NART) scores, Mini Mental 
State Examination (MMSE) scores or baseline fasting glucose levels. There was a significant 
difference between good and poor glucoregulators in terms of glucoregulation (AUC) and two-
hour post-glucose load blood glucose levels; poor glucoregulators had significantly higher 
values than good glucoregulators. In line with the WHO guidelines, both groups of participants 
had fasting blood glucose levels considered to be normoglycemic but the poor glucoregulation 
group had a mean two-hour post glucose load levels that is indicative of impaired glucose 
tolerance (IGT). 
 
INSERT TABLE 1 AND FIGURE 1 ABOUT HERE 
 
 
Stimuli 
 
The oddball task was presented using E-Prime software (E-Prime 2.0, Psychology 
Software Tools) on a Windows desktop PC. Face stimuli were obtained from the Glasgow 
Unfamiliar Face Database (Glasgow University, UK; Burton, White & McNeill, 2010). They 
were presented in the centre of the screen against a white background, standardised to a height 
of 314 pixels, with a width between 209 and 251 pixels. The oddball task comprised two test 
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blocks in which ten infrequent target faces and 240 frequent non-target faces were presented. 
The ten target faces were selected at random; five male faces and five female faces. One 
hundred and twenty faces were selected for each test block (240 faces in total); 60 randomly 
selected female faces and 60 randomly selected male faces. 
Materials 
 
OGTT and blood glucose monitoring equipment. Participants fasted overnight before 
completing an OGTT the next morning. Baseline blood glucose levels were measured by 
taking capillary blood drawn from the fingertip using Accu-Chek Safe-T-Pro Plus lancets. 
One drop of capillary blood was applied to an Optium Plus glucose reagent strip (Abbott 
Diabetes Care Ltd, Oxford, UK) for blood glucose quantification using an Optium Xceed 
glucometer (Abbott Diabetes Care Ltd, Oxford, UK). According to the manufacturer, this 
device has acceptable reliability (coefficient of variation = 3.8-5.2%) and validity (correlation 
between the Optium Xceed and a laboratory reference method is r = 0.97). Participants were 
then allowed 10 minutes to drink a solution of 75g of glucose, 200 ml of water and 30 ml of 
no-added sugar orange squash. Participant blood glucose levels were then measured 30 
minutes, 60 minutes, 90 minutes and 120 minutes post-ingestion. Following blood glucose 
measurements, participants were provided with a choice of cereal and semi-skimmed milk for 
breakfast. AUC was calculated with respect to ground (Smith & Foster, 2008; Sünram-Lea, 
Owen, Finnegan & Hu, 2010), taking into account participant fasting levels and thus 
considering total output. The following calculation was used: [((BGC30-FGC)/2) x (30-0)] + 
[{((BGC30-FGC)+(BGC60-BGC30))/2} x (60-30)] + [{((BGC60-FGC+(BGC90-FGC)/2} x 
(90-30))] + [{(BGC90-FGC + (BGC120-FGC))/2} x (120-90))] (FGC = fasting glucose 
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concentration; BGC is blood glucose concentration at that time point in minutes e.g. BGC30 
= blood glucose concentration after 30 minutes). 
National Adult Reading Test. This is a brief vocabulary test that is used as a measure of 
premorbid intellectual ability. Participants read 50 words with irregular grapheme-phoneme 
correspondence aloud (Coltheart, Patterson & Marshall, 1987) and are given a point for each 
word pronounced correctly according to English language conventions. The total score is used 
as a premorbid IQ estimate. 
Mini-mental State Examination. This test is a standardised tool used to screen for 
dementia as it allows a global assessment of any cognitive deficits. Participants are considered 
to have normal cognition if their score is equal to or higher than 25 out 30; mild cognitive 
impairment if they score 21-24; moderate cognitive impairment if they score 10-20 and severe 
cognitive impairment if their score is 9 or below. 
Familiarisation and the Oddball task. Participants were initially presented with 10 
target faces on a computer screen and asked to rate them on 9 scales by circling their answer 
on the paper questionnaire [distinctiveness, attractiveness, friendliness, approachability, 
honesty, trustworthiness, age, confidence, intelligence] (Osborne & Stevenage, 2013). They 
made these ratings three times in order for participants to familiarise themselves with the faces. 
Each face was presented for 5000 ms, allowing enough time to rate and memorise the face. 
After a five-minute interval, participants then completed an oddball task. The oddball task 
comprised two blocks separated by a two-minute interval. Within each block there were 150 
randomly presented faces: the ten target faces were presented three times each amongst 120 
previously unseen faces. A fixation cross was presented for 500 milliseconds (ms) followed by 
the stimulus for 1000 ms, and then a blank screen for 1000 ms. Participants were instructed to 
press the space bar on the keyboard every time they saw one of the ten faces they had seen and 
rated previously.  
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EEG/ERP recording and data reduction 
 
 EEG was recorded with a 32-channel electrode cap (BioSemi Active Two), fitted with 
silver/silver chloride active electrodes based on an extended 10-20 system (Jasper, 1958; 
American Electroencephalographic Society, 1994). Electroconductive gel was used to maintain 
contact between the electrodes and scalp surface. The montage included four midline sites (Fz, 
Cz, Pz and Oz), 14 sites over the left hemisphere (Fp1, AF3, F3, F7, FC1, FC5, C3, T7, CP1, 
CP5, P3, P7, PO3 and O1) and 14 sites over the right hemisphere (Fp2, AF4, F4, F8, FC2, FC6, 
C4, T8, CP2, CP6, P4, P8, PO4 and O2). The EEG signal was referenced to linked electrodes 
placed on the mastoids which were digitised at a rate of 2048 per second. Vertical electro-
oculogram was recorded via the placement of electrodes approximately 1 cm above and 1 cm 
below the left eye. 
 EEG epochs recorded from 200 ms pre-stimulus onset to 1000 ms post-stimulus onset 
were extracted for averaging. Automatic ocular artefact correction, EEG signal band-pass-
filtering at 0.46-30 Hz, artefact rejection (for trials where ERPs extended beyond the range of 
-75 to 75 μV for any channel) and ERP averaging were conducted offline using Edit 4.5 
software (Neuroscan). Trials were manually scanned to verify that the automatic ocular artefact 
correction and artefact rejection procedure had worked effectively. ERP averages were only 
used for analysis if they comprised a minimum of 16 artefact-free trials. 
EEG data was discarded from two participants due to insufficient artefact-free trials 
across each of the critical averages for the test session. A further four participants had 
insufficient artefact-free trials in the infrequent target condition. Therefore the total number of 
participants included in each of the grand averages (both infrequent target condition and 
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frequent non-target condition) was 17 overall; eight poor glucoregulators and nine good 
glucoregulators based on a median split of the area-under-the-curve measurements calculated 
from the participants’ OGTT data. The exclusion of participants did not result in any new 
between group differences across health and demographic variables. After removing 
participants, no significant differences were found in age, BMI, NART, MMSE, baseline or 
two-hour post glucose levels (although this trended towards significance [p = .064]) or in 
resting systolic and diastolic blood pressure. For the infrequent target condition, there were a 
mean number of 41 artefact-free trials for good glucoregulators and 45 artefact-free trials for 
poor glucoregulators. For the frequent non-target condition, there were a mean number of 134 
artefact-free trials for the good glucoregulators and 170 artefact-free trials for the poor 
glucoregulators. 
 
Procedure 
 
Participants attended two sessions (the interval between sessions was no longer than 
two weeks). In the first session, participants fasted overnight (at least 12 hours) before 
completing an OGTT in the morning in the lab. They completed the National Adult Reading 
test (Coltheart, Patterson & Marshall, 1987), the Mini Mental State examination (Folstein, 
Folsten & McHugh, 1975), and their height and weight were recorded. 
In the second session, participants completed the oddball task while EEG was 
simultaneously recorded. Participants were instructed to remain relaxed and as still as possible 
and to keep their eyes on the screen to minimise movement-related EEG artefacts. After 
completing the tasks, participants were debriefed and given the opportunity to ask any 
questions about the experiment. 
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Design and analysis 
 
A mixed design was used, with one between-subjects and one within-subjects factor. 
The between-subjects factor was glucoregulation group (2 levels: poor and good). The within-
subjects factor was stimulus type (2 levels: infrequent target and frequent foil). All analyses 
were Bonferroni-corrected. 
Accuracy was measured by first converting each participant’s score into a percentage 
of correct hits and false alarms. The percentage of false alarms was then subtracted from the 
percentage of hits to give a measurement of accuracy. Reaction time was the mean time taken 
by the participants to correctly identify an infrequent target face in milliseconds. 
ERP analyses were conducted for each of the four components P1, N170, P2, P3. The 
mean amplitude and peak latency for each component epoch was calculated for each 
participant. Targeted analyses comparing pairs of electrodes (one in each hemisphere against 
the other) was conducted in order to focus on specific regions related to specific processes 
rather than overall scalp locations. For the P1, N170 and P3 components, separate 2 
(hemisphere: left and right hemisphere) x 2 (group: good vs. poor glucoregulation) x 2 
(stimulus type: infrequent target vs. frequent foil) ANOVAs were run on the amplitude and 
latency data at selected electrode sites for each component. For the P2 component, separate 2 
(group) x 2 (stimulus type) ANOVAs were run on the amplitude and latency data at selected 
electrode sites for each component. On visual inspection and predicated by the literature (Gao 
et al, 2009), there appeared to be a prominent difference between the groups at occipito-parietal 
sites at the P1 time region so these have been included in the analysis (i.e. O1, O2, PO3, PO4, 
P7 and P8). Past research has revealed that the N170 component has been predominantly 
  
 
15 
detected in the right parietal hemisphere at the P8 electrode during face processing tasks 
(Rossion & Jacques, 2008). However, the N170 has also been seen in the left hemisphere and 
due to the lack of laterality often observed in older adults (Chaby et al., 2001), data analysis 
was conducted on data from Pz, P7 and P8 electrodes. Previous research has indicated that the 
P2 component is centred around frontal and central scalp locations (Riby et al, 2008) therefore 
analysis was conducted on the data from the Fz and Cz electrodes. In contrast, the P3 
component has been reported previously to be centred around central and parietal sites (Polich, 
2007) therefore analysis of this component were based on the data from the CP1, CP2, Pz and 
Cz electrodes. For all ERP analyses only significant effects are reported in text. 
 
 
Results 
 
Behavioural results 
 
Accuracy 
Based on the results of all 23 participants, an independent-samples t-test was run 
comparing the two groups. As Levene’s test of equality of variances was significant [F = 16.59, 
p = .001], equal variances were not assumed, and therefore significance values which are 
corrected for non-homogeneity of variance are reported. A significant difference was found 
between the two groups [t (11.43) = 2.81, p = .016, d = 1.22] whereby good glucoregulators 
[mean = 98.72 (SD = 2.08)] were significantly more accurate than poor glucoregulators [mean 
= 92.20 (SD = 7.43)]. 
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Reaction time 
Again, based on the results of all 23 participants, an independent-samples t-test was run 
comparing the groups on their reaction time during the task. No significant difference in 
reaction time [t (21) = 0.93, p = .37, d = .39] was found between the good glucoregulators 
[mean = 729.98 (SD = 60.99)] and the poor glucoregulators [mean = 703.93 (SD = 73.94)]. 
 
ERP results 
INSERT FIGURE 2 ABOUT HERE
P1 component 
 
 Figure 2 shows the grand average waveforms at P7, P8, PO3, PO4, O1 and O2. The 
mean amplitude and peak latency for the P1 component were taken from the 130-165 ms 
latency range based on visual inspection and previous research (Gao et al., 2009). At occipital 
sites O1 and O2, the mean amplitude data trended towards a significant main effect of group 
(p = .051), with good glucoregulators exhibiting larger mean amplitudes than poor 
glucoregulators. There was a significant main effect of hemisphere with peak latency observed 
to be significantly slower in the right hemisphere (O2) than in the left (O1) [F (1,15) = 8.07, 
MSE = 23.29, p = .012, ηp2  = .35].  
 
INSERT FIGURE 3 ABOUT HERE
 
N170 component 
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 On the basis of previous research (Chaby et al., 2001; Gao et al., 2009) and visual 
inspection, the mean amplitude and peak latency for the N170 component were taken from the 
170-235 ms latency range (Figure 3). The peak latency analysis at electrode sites P7 and P8 
revealed that there was a significant main effect of stimulus type, whereby there was a 
significantly delayed peak latency for frequent foil stimuli compared to infrequent target 
stimuli [F (1,15) = 5.80, MSE = 27.63, p = .029, ηp2  = .28]. 
 
INSERT FIGURE 4 ABOUT HERE
 
P2 component 
 
Figure 4 shows the grand average waveforms at Fz and Cz. The mean amplitude and 
peak latency for the P2 component were taken from the 180-265 ms latency range based on 
previous research and visual inspection (Riby et al., 2008). The amplitude analysis revealed 
that at Fz there was a significant main effect of group, with poor glucoregulators exhibiting a 
larger mean amplitude than those with good glucoregulation [F (1,15) = 4.72, MSE = 9.48, p 
= .042, ηp2  = .25]. For peak latency, at Fz there was a significant main effect of group, whereby 
participants with poor glucoregulation had a significantly delayed peak latency than those with 
good glucoregulation [F (1,15) = 5.11, MSE = 446.55, p = .039, ηp2  = .25].  
 
INSERT FIGURE 5 ABOUT HERE 
 
P3 component 
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The mean amplitude and peak latency for the P3 component (Figure 5) were taken from 
the 545-780 ms latency range based on visual inspection of the data and in line with previous 
research (Daniel & Bentin, 2012). For peak latency, there was a significant three-way 
interaction between hemisphere, stimulus type and group at sites CP1 and CP2 [F (1, 15) = 
6.30, MSE = 273.41, p = .024, ηp2 = .30]. Post-hoc analysis revealed that for participants with 
poor glucoregulation, there were no significant main effects of hemisphere or stimulus type 
and no significant interaction was found. However, participants with good glucoregulation 
showed no significant main effects of hemisphere or stimulus type but a significant interaction 
between hemisphere and stimulus type [F (1, 8) = 6.78, MSE = 334.14, p = .031, ηp2  = .46] 
was observed; the difference between target and foil stimuli latency at CP1 approached 
significance (p = .057), with peak latency slower for target than for foil stimuli. 
ERPs and behaviour 
 
P1 component 
 
 Overall, no significant correlations between behavioural performance and i) mean 
amplitude or ii) peak latencies across any of the electrodes were observed. This result held 
when each glucoregulatory group was analysed separately. 
 
N170 component 
 
 Table 2 shows the correlations between the N170 mean amplitude and peak latencies 
with behavioural accuracy and hits. In terms of peak latency, at P7, accuracy was significantly 
negatively associated for both infrequent target faces and frequent non-target faces (p = .03 and 
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p = .009 respectively). The number of hits was also significantly negatively associated with 
frequent non-target stimulus peak latency (p = .012). At P8, both accuracy and number of hits 
were negatively correlated with the non-target faces (p = .011 and p = .024 respectively).  
 For good glucoregulators, the N170 latency data indicated peak latency for target 
stimuli at electrode site P7 was significantly negatively correlated with both number of hits (p 
= .04) and accuracy (p = .02). Peak latency for non-target faces was also significantly 
negatively correlated with both number of hits (p = .047) and accuracy (p = .048).  
 
INSERT TABLE 2 ABOUT HERE 
 
P2 component 
 
 As indicated by Table 3, the peak latencies observed for target and non-target faces at 
Fz and Cz were all significantly negatively correlated with both accuracy and number of hits. 
 For poor glucoregulators, the P2 latency data revealed that peak latency for targets at 
electrode site Cz was significantly negatively associated with both number of hits (p = .04) and 
accuracy (p = .02). 
 
INSERT TABLE 3 ABOUT HERE
 
P3 component 
 
 Table 4 shows the overall correlations between behavioural performance, mean 
amplitude and peak latencies of the P3 component. For peak latency, at CP1, both accuracy 
and number of hits were significantly negatively associated with P3 peak latency (p = .006 and 
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p = .02 respectively). At CP2, accuracy was also significantly negatively correlated with P3 
peak latency (p = .04). 
 For good glucoregulators, peak latency for target stimuli at electrode sites Pz and Cz 
were both significantly correlated with accuracy (p = .05 and p = .02 respectively). Peak latency 
for frequent non-target foils were significantly negatively correlated with accuracy at electrode 
sites CP1 (p = .03), Pz (p = .001), and CP2 (p = .02). Peak latency for non-targets was also 
significantly negatively correlated with number of hits at electrode sites Pz (p = .001) and CP2 
(p = .03). For poor glucoregulators, there was a significant positive correlation between the 
number of hits and mean amplitude for non-targets at electrode site Cz (p = .04). In terms of 
peak latency, there were significant negative associations between peak latency for non-targets 
at electrode site CP1, and number of hits (p = .04), as well as accuracy (p = .04).  
 
INSERT TABLE 4 ABOUT HERE 
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Discussion 
 
 The aim of the current study was to investigate further the neurocognitive mechanisms 
underpinning face recognition deficits in older adults with compromised glucoregulatory 
efficiency. This was achieved by moving beyond behavioural methods alone and tracking ERPs 
during a 2-stimulus oddball task. The behavioural results indicated that those with good 
glucoregulation were significantly more accurate at recognising the ten target (familiar) faces 
compared to those with poor glucoregulation. This finding is aligned with previous work which 
has observed face recognition deficits in individuals with compromised glucoregulatory 
efficiency (Zaslavsky et al., 1995; Fontbonne et al., 2001; Jones et al., 2016). However, the 
primary concern here was using the temporal precision of ERPs to uncover the specific 
mechanisms impaired during the task, which may account for face recognition deficits.  
Perhaps the most noteworthy ERP finding observed was that poor glucoregulators 
exhibited significantly greater mean amplitudes and delayed peak latencies than good 
glucoregulators at midline frontal sites. The correlational data further indicates that peak 
latency was significantly associated with behavioural performance: for target stimuli at 
electrode site Cz, delayed peak latency was associated with poorer behavioural performance 
(number of hits and accuracy). In oddball tasks, the P2 component is considered to index 
attentional processing of stimuli (Riby et al., 2008) and in face processing has been found to 
be reduced and delayed in older adults (Wolff et al., 2012). Further, the P2 component has been 
associated with early individuation and thus identification of faces (Zheng et al., 2012) and 
may therefore reflect attention to and identification encoding of a face. At occipito-parietal 
sites, smaller P2 amplitudes have been found to correlate with stronger identification of faces 
(Zheng et al., 2012). The present study findings are align with a previous behavioural finding 
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in which older adults with DM2 exhibited relatively poor performance on a face recognition 
task which relies predominantly on attentional as opposed to memory processing (Fontbonne 
et al., 2001). Consequently, these findings suggest that face recognition deficits observed in 
poor glucoregulators may be a consequence of impaired attentional processing requiring more 
effort to process/encode faces. 
Previous investigations of the effects of ageing on face processing and recognition have 
indicated that older adults exhibit larger P1 and N170 amplitudes when presented with face 
stimuli compared to young adults (Gao et al., 2009). Therefore, based on the notion that poorer 
glucoregulatory efficiency in older age is an index of cognitive decline (Meikle et al., 2004), it 
was predicted that poor glucoregulators would exhibit larger and delayed P1 and N170 
amplitudes than good glucoregulators. However, the results of the current study revealed no 
difference in P1 and N170 amplitude or latency between the two groups. This finding is 
consistent with a previous report that alterations in glucose metabolism do not affect the P1 
component (Seaquist et al., 2007). The correlational data also indicated minimal significant 
associations between the P1 and N170 mean amplitudes with behavioural performance. Taken 
together, these findings suggest that face recognition deficits in older adults with compromised 
glucoregulatory efficiency are not accounted for by impaired perceptual processing, nor early 
face perceptual processes. 
It was predicted that participants with poor glucoregulation would have delayed P3 
latencies relative to good glucoregulators. However, the results presented here revealed no 
differences in amplitude or latency between the two glucoregulatory groups. This contradicts 
previous research that has found differences in P3 latency between adults with DM2 and 
healthy controls (Cooray et al., 2011; Hissa et al., 2002) and suggests that face recognition 
deficits in poor glucoregulators are not modulated by memory updating. A major difference 
between the present study and previous studies which have observed delayed P3 latencies in 
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individuals with DM2 is that the previous work used auditory memory paradigms; thus this 
effect may not hold when stimuli is presented visually as was the case here. Equally, the effect 
may not be present in individuals who do not have chronically impaired glucose tolerance. In 
terms of correlations between the P3 component and behavioural performance, it was evident 
in both groups that delayed peak latency equated to poorer accuracy on the face recognition 
task. There was also some evidence to suggest an increase in P3 amplitude with better 
behavioural performance. These correlations indicate a possible relationship between the P3 
component and face recognition performance, similar to that observed for the P2 component. 
However, this was not moderated by glucoregulatory efficiency. On this basis, it seems 
appropriate to speculate that face recognition deficits in older adults with relatively poorer 
glucoregulatory efficiency may be underpinned by impairments in attentional mechanisms as 
opposed to memory processes. This is a novel finding that has not been previously considered 
in the literature. 
The underlying physiological mechanisms that are responsible for the observed 
cognitive impairments have yet to be elucidated, but several possible mechanisms have been 
proposed. These include hyperglycaemia, hypertension and hypothalamic-pituitary-adrenal 
(HPA) axis dysregulation (Strachan, Reynolds, Marioni & Price, 2011). The most pertinent 
mechanism in the current study is hyperglycaemia, as a result of increased insulin resistance 
and/or decreased insulin sensitivity. An association has been reported between insulin 
resistance, cognitive impairment and reduced brain size in middle-aged and older adults (Baker 
et al., 2011; Benedict et al., 2012; Tan et al., 2011), and desensitisation of insulin receptors 
within the brain have been suggested to play a role in Alzheimer’s Disease (Hoyer, 2002). 
Thus, deterioration of brain insulin signalling may potentially explain the cognitive impairment 
experienced by individuals with poor glucose regulation (Kravitz, Schmeidler & Beeri, 2013). 
It has been suggested that the increased blood glucose concentration that results from 
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hyperglycaemia causes alterations in regional cerebral blood flow and may also cause changes 
to endothelial cells within the brain (Strachan et al., 2011). Speculatively, the observed 
impairments in attentional mechanisms in the current study may be caused by disruptions in 
uptake of glucose within the fronto-parietal network, where visual attentional processing is 
considered to take place (Kanwisher & Wojciulik, 2000). Another potential mechanism that 
has been linked to cognitive decline in individuals with poor glucoregulatory efficiency is 
hypertension (van den Berg, Kloppenberg, Kessels, Kappelle, & Biessels, 2009). Increases in 
blood pressure have been associated with atrophy in frontal brain regions in individuals with 
DM2 (Sakurai et al., 2006) and given the relatively high mean baseline blood pressures of the 
participants within the current study, this may explain the observed impairments in attentional 
processing. Initial damage as a result of comorbid hypertension to the frontal lobes may result 
in both the behavioural and ERP observations of the current study. HPA axis dysregulation, 
resulting in increased levels of cortisol within the bloodstream, has been suggested as another 
potential explanation of cognitive decline in individuals with poor glucoregulatory efficiency 
(Strachan et al., 2011). For example, in patients with DM2, high morning cortisol levels have 
been associated with cognitive impairment (Reynolds et al., 2010). Considering that the present 
study investigated cognitive performance in terms of memory accuracy (relating to the oddball 
face), future research could include the investigation of cortisol levels as a potential factor, 
particularly given that exposure of the hippocampus to glucocorticoids has been associated 
with cognitive decline in ageing (McEwen, 1999). 
A number of limitations must be considered. One limitation that should be noted is that 
the sample size is small, however the sample size was comparable with previous similar studies 
(e.g. Riby et al., 2008; Schultes et al., 2005; Smith et al., 2009). Further, while the use of the 
median split to divide participants within this study into poor and good glucoregulators is a 
feature of previous studies in this area (Messier et al., 2011; Messier et al., 2010; Messier, 
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Tsiakas, Gagnon, Desrochers & Awad, 2003), glucose tolerance is considered to be a 
continuum and therefore dichotimising this variable may lead to an increased risk of type 1 
error (Austin & Brunner, 2004; MacCullum, Zhang, Preacher & Rucker, 2002). Those 
participants who have OGTT AUC results that lie close to the median (whether below or above) 
may not vary drastically, particularly given that glucose regulation is likely to be reasonably 
normally distributed, thus the values of many participants will cluster around the median. A 
larger sample would have allowed a comparison of participants with and without clinically 
impaired glucose tolerance (in accordance with WHO guidelines). Future, larger studies could 
overcome this issue by making use of more sophisticated analysis techniques which require 
larger sample sizes, such as linear mixed modelling. It should also be noted that the age 
difference between the two glucoregulatory groups did approach significance (p = .10) and thus 
ageing may have contributed to the observed differences in ERPs and behaviour. Considering 
that there is an established relationship between age, cognitive decline and impaired glucose 
tolerance (Lamport et. al, 2009), this difference is not surprising but future research should 
consider age-matching the groups more closely to rule this out as a contributing factor. Future 
research should look to control more appropriately for clinically relevant features of 
prediabetes and diabetes, including elevated blood pressure, waist circumference, triglycerides 
and reduced HDL-C. Nevertheless, given that these clinical features are part of the clinical 
profile of individuals with glucoregulatory problems, we did not want to exclude participants 
on this basis. A final limitation is that no nutritional restrictions were placed on participants 
prior to the second session and no data relating to glucose levels was retrieved from participants 
during this session. As such, the ingestion of carbohydrates and consumption of caffeine may 
have had an influence on the results. It is typical of research in this area not to conduct an 
OGTT on the day of testing in order not to fatigue participants, and to rule out the influence of 
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either fasting or a glucose load on task performance (e.g. Messier et al., 2003; Messier et al., 
2010).    
In summary, the present study investigated the influence of glucoregulation on face 
processing and recognition in healthy older adults using an ERP oddball paradigm, with the 
aim of identifying the neurocognitive mechanisms that underpin face recognition deficits in 
individuals with compromised glucoregulatory efficiency. To the best of our knowledge, this 
is the first study to systematically investigate the mechanisms underpinning the face 
recognition deficits associated with impaired glucose regulation. The findings indicated that 
glucoregulation did not appear to impact upon early visual processing (the P1 and N170 
components) or memory updating/formation (the P3 component), but did appear to modulate 
attentional processing, specifically, early individuation and recognition of faces (the P2 
component). It is important to note, that whilst the glucoregulatory indices of those participants 
with relatively poor glucoregulation reflected IGT, the results may not necessarily be 
extrapolated to those with chronically compromised glucoregulatory efficiency (i.e. DM2). 
Future work should aim to replicate these findings in individuals with DM2, given that face 
recognition deficits are a known feature of the DM2 cognitive profile (Jones et al., 2016). This 
is particularly important given that a decline in attentional processing capacity in DM2 may 
impact upon face recognition and other cognitive processes which are important for everyday 
functional living. Further, strategies could be put in place early to aid those with poor 
glucoregulation who suffer with face recognition deficits. By implementing strategies that aid 
with maintaining attention, such as cueing or focussing on internal facial features, deficits in 
face recognition may be alleviated. To conclude, the temporal resolution of the ERP technique 
employed in this study has enabled us to ascertain, for the first time, that compromised 
glucoregulatory efficiency potentially impacts upon structural encoding and attentional 
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mechanisms which are required to successfully recognise faces, but that later memory 
consolidation and earlier perceptual processes are unaffected by glucoregulatory status. 
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Table 1. Participant characteristics (mean and SD) 
 
 Good 
glucoregulators 
(n=12) 
Poor 
glucoregulators 
(n=11) 
p 
Age 71.08 (7.59) 76.91 (8.53) .10 
BMI 26.89 (6.08) 26.56 (6.01) .90 
NART 37.83 (7.97) 41.55 (4.80) .20 
MMSE 28.08 (1.62) 28.09 (1.70) .99 
AUC (mmol/l) 429.88 (114.43) 825.14 (178.05) <.001* 
Baseline fasting glucose level 
(mmol/l) 
5.03 (0.49) 5.13 (0.36) .58 
Two-hour post glucose load 
level (mmol/l) 
6.39 (1.36) 8.65 (2.14) .006* 
Resting systolic blood 
pressure (mmHg) 
134.27 (15.84) 138.09 (15.52) .57 
Resting diastolic blood 
pressure (mmHg) 
83.27 (8.51) 74.64 (10.69) .049* 
*indicates p<.05 
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Table 2. Correlations between behavioural performance, and N170 mean amplitude and peak latency to targets and non-targets in good and poor 
glucoregulators. 
      P7 Pz P8 
   target  non-target target  non-target target  non-target 
N170 Amplitude Good glucoregulators Hits -.330 -.407 -.335 -.284 -.379 -.348 
  Accuracy -.524 -.611 -.355 -.355 -.486 -.496 
 Poor glucoregulators Hits .461 .450 .206 .310 -.175 -.255 
  Accuracy .463 .407 .200 .293 -.260 -.349 
 Overall Hits 0.115 0.094 -0.033 0.059 -0.224 -0.24 
  Accuracy 0.032 -0.016 -0.083 -0.006 -0.316 -0.337 
         
N170 Latency Good glucoregulators Hits -.696* -.673* -.039 .107 -.270 -.466 
  Accuracy -.746* -.671* .044 .151 -.400 -.476 
 Poor glucoregulators Hits -.396 -.654 -.109 -.085 -.168 -.648 
  Accuracy -.397 -.647 -.075 -.051 -.274 -.698 
 Overall Hits -0.465 -.593* -0.041 0.011 -0.194 -.544* 
    Accuracy -.519* -.614* 0.001 0.057 -0.292 -.597* 
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* indicates p <.05 
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Table 3. Correlations between behavioural performance, and P2 mean amplitude and peak 
latency to targets and non-targets in good and poor glucoregulators. 
      Fz Cz 
   
target 
 non-
target 
target 
 non-
target 
P2 Amplitude 
Good 
glucoregulators 
Hits -.406 -.374 -.257 -.305 
  Accuracy -.280 -.402 -.240 -.360 
 
Poor 
glucoregulators 
Hits -.292 -.173 -.368 -.108 
  Accuracy -.233 -.158 -.342 -.114 
 Overall Hits -0.425 -0.351 -0.433 -0.273 
  Accuracy -0.414 -0.391 -0.45 -0.323 
       
P2 Latency 
Good 
glucoregulators 
Hits -.494 -.565 -.177 -.271 
  Accuracy -.418 -.603 -.258 -.444 
 
Poor 
glucoregulators 
Hits -.679 -.492 -.737* -.533 
  Accuracy -.705 -.522 -.796* -.580 
 Overall Hits -.641** -.536* -.634** -.539* 
    Accuracy -.675** -.598* -.686** -.605* 
* indicates p <.05 
**indicates p <.01 
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Table 4. Correlations between behavioural performance, and P3 mean amplitude and peak latency to targets and non-targets in good and poor 
glucoregulators. 
      CP1 Cz CP2 Pz 
   
target 
 non-
target 
target 
 non-
target 
target 
 non-
target 
target 
 non-
target 
P3 Amplitude 
Good 
glucoregulators 
Hits .535 -.147 .627 -.129 .627 -.112 .556 .029 
  Accuracy .527 .023 .545 -.014 .656 .043 .625 .221 
 
Poor 
glucoregulators 
Hits .593 .623 .590 .731* .533 .591 .469 .488 
  Accuracy .581 .578 .582 .685 .514 .554 .454 .469 
 Overall Hits 0.463 0.385 0.453 0.367 0.376 0.273 0.341 0.319 
  Accuracy 0.437 0.349 0.422 0.318 0.346 0.242 0.322 0.309 
           
P3 Latency 
Good 
glucoregulators 
Hits -.544 -.662 -.653 -.557 -.474 -.715* -.661 -.910** 
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  Accuracy -.567 -.708* -.753* -.597 -.562 -.741* -.671* -.909** 
 
Poor 
glucoregulators 
Hits -.595 -.736* .096 -.629 -.454 -.434 -.406 -.383 
  Accuracy -.607 -.784* .080 -.670 -.476 -.493 -.473 -.473 
 Overall Hits -0.394 -.579* -0.16 -0.46 -0.382 -0.356 -0.273 -0.371 
    Accuracy -0.441 -.641* -0.25 -.510* -0.449 -0.424 -0.345 -0.464 
* indicates p <.05 
**indicates p <.01 
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Figure 1. OGTT data for good and poor glucoregulators (0 represents baseline fasting levels; 
standard errors shown in error bars). 
 
Figure 2. The grand average ERPs at electrode sites P7, P8, PO3, PO4, O1 and O2. ERPs for 
the infrequent targets and frequent non-targets of both good and poor glucoregulators are 
displayed for the P1 component (130 – 165 ms, light blue shading). 
 
Figure 3. The grand average ERPs at electrode sites P7, Pz, and P8. ERPs for the infrequent 
targets and frequent non-targets of both good and poor glucoregulators are displayed for the 
N170 component (170 – 235 ms, green shading). 
 
Figure 4. The grand average ERPs at electrode sites Fz and Cz. ERPs for the infrequent 
targets and frequent non-targets of both good and poor glucoregulators are displayed for the 
P2 component (180 – 265 ms, dark blue shading). 
 
Figure 5. The grand average ERPs at electrode sites Cz, CP1, CP2 and Pz. ERPs for the 
infrequent targets and frequent non-targets of both good and poor glucoregulators are 
displayed for the P3 component (545 – 780 ms, purple shading).   
  
 
 
 
